Document is current

Any future updates will be listed below

Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumab

Crossref DOI link: https://doi.org/10.1186/s40425-017-0272-z

Published Online: 2017-08-15

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark